Trial Profile
Clinical Trials Insight: 700037573
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 30 Sep 2008
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 30 Sep 2008 New trial record.